# FDA Inspection 1226417 - David Liao, M.D. - January 03, 2024

Source: https://www.keypedia.com/records/fda_inspections/david-liao-md/67be8d66-b0b3-4796-b530-ea478533707e
Source feed: FDA_Inspections

> FDA Inspection 1226417 for David Liao, M.D. on January 03, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226417
- Company Name: David Liao, M.D.
- Inspection Date: 2024-01-03
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1226417 - 2024-01-03](https://www.keypedia.com/records/fda_inspections/david-liao-md/5b5c50d5-3a7b-4d58-99f1-05fdc6b92450)

Company: https://www.keypedia.com/companies/david-liao-md/9da2c04d-a053-49c6-827b-3d8f6a1f75aa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d